Following the promising results with tau deposits in the Tg4510 mouse model, we investigated whether L095 could label tau deposits in post-mortem brain samples from patients with advanced Alzheimer’s disease neuropathology. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.